Alnylam Pharmaceuticals Inc <ALNY.O>: Citigroup cuts target price to $340 from $380
ALNY•Related News
Alerus Financial Corp <ALRS.O>: Raymond James raises target price to $37 from $34
ALRS•
Crescent Biopharma grants employee stock options for 19,425 shares at $14.47 each
CBIO•
Tesla's European registrations uneven in July despite broader EV momentum
TSLA•
PBF Energy Inc <PBF.N>: JP Morgan Raises Target Price to $83 From $57
PBF•
Regenxbio schedules conference call to discuss second-quarter results and operational update
RGNX•